Steven Cohen Adverum Biotechnologies, Inc. Call Options Transaction History

Point72 Asset Management, L.P.

2 transactions

Quarter	Operation	Price Per call	calls change	calls Held	SEC Form
Q2 2021 Aug 16, 2021	SELL	$3.36 - $10.56 $532,224 - $1.67 Million	-158,400 Closed	0 $0
Q1 2021 May 17, 2021	BUY	$9.26 - $14.36 $1.47 Million - $2.27 Million	158,400 New	158,400 $1.56 Million

524K

Ticker ADVM
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 99,333,600
Market Cap $611M
Description
Adverum Biotechnologies, Inc., a clinical-stage gene therapy company, develops gene therapy product candidates to treat ocular and rare diseases. Its lead product candidate is ADVM-022, a single intravitreal injection gene therapy candidate used for the treatment of patients with chronic retinal, including wet age-related macular degeneration an...

Get notified when there are updates to the investment portfolio of Point72 Asset Management, L.P., based on Form 13F filings with the SEC.

Stay updated on Point72 Asset Management, L.P. and Steven Cohen with notifications on news.